Garratty G. Predicting the clinical significance of alloantibodies and determining the in vivo survival of transfused red cells. In: Judd WJ, Barnes A, eds. Clinical and serological aspects of tramsfusion reactions. Arlington, VA: American Association of Blood Banks, 1982:91–119.Search in Google Scholar
Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449–52.10.1046/j.1537-2995.1987.27688071692.x3686653Search in Google Scholar
Shoeppncr-Estey S, Girin J, Mallory D, Davey R, A comparison of the monocyte monolayer assay to the 51Chromium (51Cr) red cell survival for determining the clinical significance of red cell alloantibodies (abstract). Blood 1986;68:302a.Search in Google Scholar
Baldwin ML, Ness PM, Barrasso C, et al. In vivo studies of long term 51Cr red cell survival for determining the clinical significance of red cell alloantibodies. Transfusion 1985;25:34–8.10.1046/j.1537-2995.1985.25185116499.x3969699Search in Google Scholar
Eaton BR. Morton JA, Pickles MM, White KE. A new antibody. anti-Yta, characterizing a blood group antigen of high incidence. Br J Haematol 1956;2:333–41.10.1111/j.1365-2141.1956.tb06707.x13383099Search in Google Scholar
Dobbs JV, Prutting DL, AdebahrMA. Allen EH, Alter AA. Clinical experience with three examples of anti-Yta. Vox Sang 1968; 15:216–21.10.1111/j.1423-0410.1968.tb01752.x5683382Search in Google Scholar
Bettigole R, Hams JP, Tegoli J, Issitt PD. Rapid in vivo destruction of Yt(a+) red cells in a patient with anti-Yta. Vox Sang 1968;14:143–6.Search in Google Scholar
Gobel U, Drescher KH, Pottgen W, Lehr HJ. A second example of anti-Yta with rapid in vivo destruction of Yta red cells. Vox Sang 1974;27:171–5.Search in Google Scholar
International Committee for Standardization in Hematology. Recommended methods for radioisotope red cell survival studies. Blood 1971;38:378–86.10.1182/blood.V38.3.378.378Search in Google Scholar
Issitt PD. Applied blood group serology, 3rd ed. Miami, FL: Montgomery Scientific Publications. 1985:387–8.Search in Google Scholar
AuBuchon JP, Brightman A, Anderson HA, Kim B. An example of anti-Yta demonstrating a change in its clinical significance. Vox Sang 1988;55:171–5.Search in Google Scholar
Davey RJ, Simpkins SS. 51Chromium survival of Yt(a+) red cells as a determinant of the in vivo significance of anti-Yta. Transfusion 1982;21:702–5.Search in Google Scholar